A Human Cytome Project - References

A human cytome project aims at creating a better understanding of a cellular level of biological complexity in order to allow us to close the gap between (our) molecules and the intrahuman ecosystem. Understanding the (heterogeneous) cellular level of biological organisation and complexity is (almost) within reach of present day science, which makes such a project ambitious but achievable. A human cytome project is about creating a solid translational science, not from bench to bedside, but from molecule to man.

References

  • Abraham VC, Taylor DL, Haskins JR., High content screening applied to large-scale cell biology, Trends Biotechnol. 2004 Jan;22(1):15-22.
  • Achenbach TV, Brunner B, Heermeier K., Oligonucleotide-based knockdown technologies: antisense versus RNA interference, Chembiochem. 2003 Oct 6;4(10):928-35..
  • Adams MC, Salmon WC, Gupton SL, Cohan CS, Wittmann T, Prigozhina N, Waterman-Storer CM., A high-speed multispectral spinning-disk confocal microscope system for fluorescent speckle microscopy of living cells, Methods. 2003 Jan; 29(1):29-41.
  • Aitchison J.D, Galitski, T., Inventories to insights, The Journal of Cell Biology 2003; 161:3, 465–469.
  • Alanine A, Nettekoven M, Roberts E, Thomas AW., Lead generation--enhancing the success of drug discovery by investing in the hit to lead process, Comb Chem High Throughput Screen. 2003 Feb; 6(1):51-66.
  • Albert JM, Demets DL., On a model-based approach to estimating efficacy in clinical trials, Stat Med 1994 Nov;13(22):2323-2335.
  • Alexander, S., Hellemans, L., Marti, O., Schneir, J., Elings, V., Hansma, P.K., Longmiro, M., and Gurley, J., An atomic-resolution atomic-force microscope implemented using an optical lever. J. Appl. Phys. 1989, 65(1), 164-167
  • Alivisatos, A. P., The Use of Nanocrystals in Biological Detection, Nature Biotech. 2004, 22:47-52.
  • Alwine JC, Kemp DJ, Stark GR., Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes, Proc Natl Acad Sci U S A. 1977 Dec;74(12):5350-4.
  • Alwine JC, Kemp DJ, Parker BA, Reiser J, Renart J, Stark GR, Wahl GM, Detection of specific RNAs or specific fragments of DNA by fractionation in gels and transfer to diazobenzyloxymethyl paper, Methods Enzymol. 1979; 68:220-42.
  • Andrews PD, Harper IS, Swedlow JR., To 5D and beyond: quantitative fluorescence microscopy in the postgenomic era, Traffic. 2002 Jan; 3(1):29-36.
  • Apic G, Ignjatovic T, Boyer S, Russell RB., Illuminating drug discovery with biological pathways, FEBS Lett. 2005 Mar 21;579(8):1872-7.
  • Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S, Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death, Nature. 2004 Oct 14;431(7010):805-10.
  • Audrezet MP, Chen JM, Raguenes O, Chuzhanova N, Giteau K, Le Marechal C, Quere I, Cooper DN, Ferec C, Genomic rearrangements in the CFTR gene: extensive allelic heterogeneity and diverse mutational mechanisms, Hum Mutat. 2004 Apr;23(4):343-57.
  • Autumn A. Cuellar, Poul F. Nielsen, David P. Bullivant, and Peter J. Hunter, CellML 1.1 for the Definition and Exchange of Biological Models. Conf. Proc. 2003 IFAC Symposium on Modelling and Control in Biomedical Systems. 2003 Nov; 451-456.
  • Ayoubi TA, Van De Ven WJ, Regulation of gene expression by alternative promoters, FASEB J. 1996 Mar;10(4):453-60.
  • Bacskai BJ, Hickey GA, Skoch J, Kajdasz ST, Wang Y, Huang GF, Mathis CA, Klunk WE, Hyman BT., Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice, Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12462-7. Epub 2003 Sep 29.
  • Bader JS., The relative power of SNPs and haplotype as genetic markers for association tests, Pharmacogenomics. 2001 Feb; 2(1):11-24.
  • Baghdoyan S, Roupioz Y, Pitaval A, Castel D, Khomyakova E, Papine A, Soussaline F, Gidrol X., Quantitative analysis of highly parallel transfection in cell microarrays, Nucleic Acids Res. 2004 May 21;32(9):e77.
  • Bailey DG, Spence JD, Munoz C, Arnold JM., Interaction of citrus juices with felodipine and nifedipine, Lancet. 1991 Feb 2;337(8736):268-9.
  • Bailey SN, Wu RZ, Sabatini DM., Applications of transfected cell microarrays in high-throughput drug discovery, Drug Discov Today. 2002 Sep 15;7(18 Suppl):S113-8.
  • Baksh D, Song L, Tuan RS., Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy, Cell Mol Med. 2004 Jul-Sep; 8(3):301-16.
  • Banan M, Puri N., The ins and outs of RNAi in mammalian cells, Curr Pharm Biotechnol. 2004 Oct; 5(5):441-50.
  • Barbieri RL, Gao X, 17 beta-Hydroxysteroid dehydrogenase: enzymatic activity and mRNA species in choriocarcinoma cells, Gynecol Obstet Invest. 1994;37(3):210-4.
  • Barker J, Garner RC., Biomedical applications of accelerator mass spectrometry-isotope measurements at the level of the atom, Rapid Commun Mass Spectrom. 1999;13(4):285-93.
  • Barroso I, et al., Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension, Nature. 1999 Dec 23-30;402(6764):880-3.
  • Bassingthwaighte JB., Toward modeling the human physionome, Adv Exp Med Biol. 1995; 382:331-9.
  • Bassingthwaighte JB., Strategies for the physiome project, Ann Biomed Eng. 2000 Aug; 28(8):1043-58.
  • Bassoe C.F., Li N, Ragheb K, Lawler G, Sturgis L, J. , Robinson P.J., Cytometric Investigations of Phagosomes, Mitochondria and Acidic Granules in Human neutrophils, Cytometry 2003 Jan;51B(1):21-9.
  • Bayer voluntarily withdraws Baycol, AWHONN Lifelines. 2001 Oct-Nov;5(5):21.
  • Benson ES., Leukemia and the Philadelphia chromosome, Postgrad Med. 1961 Dec;30:A22-A28.
  • Berends M., Maex R., De Schutter E., A detailed three-dimensional model of the cerebellar granular layer, Neurocomputing 2004, 58-60, 587-592.
  • Berg EL, Hytopoulos E, Plavec I, Kunkel EJ., Approaches to the analysis of cell signaling networks and their application in drug discovery, Curr Opin Drug Discov Devel. 2005 Jan; 8(1):107-14.
  • Berger A, Drosten Ch, Doerr HW, Sturmer M, Preiser W, Severe acute respiratory syndrome (SARS)--paradigm of an emerging viral infection, J Clin Virol. 2004 Jan; 29(1):13-22.
  • Berger EG., Ectopic localizations of Golgi glycosyltransferases., Glycobiology. 2002 Feb; 12(2):29R-36R.
  • Bergstrom M, Grahnen A, Langstrom B., Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug development, Eur J Clin Pharmacol. 2003 Sep;59(5-6):357-66. Epub 2003 Aug 22.
  • Berns K, Hijmans EM, Mullenders J, Brummelkamp TR, Velds A, Heimerikx M, Kerkhoven RM, Madiredjo M, Nijkamp W, Weigelt B, Agami R, Ge W, Cavet G, Linsley PS, Beijersbergen RL, Bernards R., A large-scale RNAi screen in human cells identifies new components of the p53 pathway, Nature. 2004 Mar 25; 428(6981):431-7.
  • Berridge MJ., The endoplasmic reticulum: a multifunctional signaling organelle, Cell Calcium. 2002 Nov-Dec;32(5-6):235-49.
  • Berridge MJ., Phosphatidylinositol hydrolysis and calcium signalling, Adv Cyclic Nucleotide Res. 1981;14:289-99.
  • Berridge MJ., Cardiac calcium signalling, Biochem Soc Trans. 2003 Oct;31(Pt 5):930-3.
  • Berridge MJ, Bootman MD, Roderick HL., Calcium signalling: dynamics, homeostasis and remodelling, Nat Rev Mol Cell Biol. 2003b Jul;4(7):517-29.
  • Berridge MJ., Unlocking the Secrets of Cell Signaling, Annu Rev Physiol. 2004 Jul 16.
  • Bers DM., Dynamic imaging in living cells: windows into local signalling, Sci STKE. 2003 Apr 8; 2003(177):PE13. Print 2003 Apr 8.
  • Betz UA, Farquhar R, Ziegelbauer K., Genomics: success or failure to deliver drug targets?, Curr Opin Chem Biol. 2005 Aug;9(4):387-91.
  • Bjornsson HT, Fallin MD, Feinberg AP., An integrated epigenetic and genetic approach to common human disease, Trends Genet. 2004 Aug;20(8):350-8.
  • Bila V, Kren V., The significance of genetic factors for thalidomide teratogenicity in the Norway rat, Acta Univ Carol [Med] (Praha). 1989;35(1-2):3-10.
  • Bilello JA., The agony and ecstasy of "OMIC" technologies in drug development, Curr Mol Med. 2005 Feb;5(1):39-52.
  • Blair JE, Evaluation of fever in the international traveler. Unwanted 'souvenir' can have many causes, Postgrad Med. 2004 Jul;116(1):13-20, 29.
  • Bleicher KH, Bohm HJ, Muller K, Alanine AI., Hit and lead generation: beyond high-throughput screening, Nat Rev Drug Discov. 2003 May;2(5):369-78.
  • Bohets H, Annaert P, Mannens G, Van Beijsterveldt L, Anciaux K, Verboven P, Meuldermans W, Lavrijsen K., Strategies for absorption screening in drug discovery and development, Curr Top Med Chem. 2001 Nov;1(5):367-83.
  • Bootman MD, Collins TJ, Peppiatt CM, Prothero LS, MacKenzie L, De Smet P, Travers M, Tovey SC, Seo JT, Berridge MJ, Ciccolini F, Lipp P., Calcium signalling--an overview, Semin Cell Dev Biol. 2001 Feb;12(1):3-10.
  • Bootman MD, Berridge MJ, Roderick HL., Calcium signalling: more messengers, more channels, more complexity, Curr Biol. 2002 Aug 20;12(16):R563-5.
  • Borgers M, Thone F, Ver Donck L., Sarcolemma-bound calcium. Its importance for cell viability, Basic Res Cardiol. 1985; 80 Suppl 1:30-5.
  • Borgers M, Ver Donck L, Vandeplassche G., Pathophysiology of cardiomyocytes, Ann N Y Acad Sci. 1988; 522:433-53.
  • Bothe GW, Bolivar VJ, Vedder MJ, Geistfeld JG., Genetic and behavioral differences among five inbred mouse strains commonly used in the production of transgenic and knockout mice, Genes Brain Behav. 2004 Jun;3(3):149-57.
  • Braet F, de Zanger R, Seynaeve C, Baekeland M, Wisse E., A comparative atomic force microscopy study on living skin fibroblasts and liver endothelial cells, J Electron Microsc (Tokyo). 2001;50(4):283-90.
  • Braunschweig T, Chung JY, Hewitt SM., Perspectives in tissue microarrays, Comb Chem High Throughput Screen. 2004 Sep;7(6):575-85.
  • Bright GR, Fisher GW, Rogowska J, Taylor DL, Fluorescence ratio imaging microscopy, Methods Cell Biol. 1989;30:157-92.
  • Butcher EC., Can cell systems biology rescue drug discovery?, Nat Rev Drug Discov. 2005 Jun;4(6):461-7. Review.
  • Brookes ST, Whitley E, Peters TJ, Mulheran PA, Egger M, Davey Smith G., Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives, Health Technol Assess. 2001; 5(33):1-56.
  • Broussard LA, Biological agents: weapons of warfare and bioterrorism, Mol Diagn. 2001 Dec;6(4):323-33.
  • Brown K, Tompkins EM, White IN., Applications of accelerator mass spectrometry for pharmacological and toxicological research, Mass Spectrom Rev. 2006 Jan-Feb;25(1):127-45.
  • Brusa R., Genetically modified mice in neuropharmacology, Pharmacol Res. 1999 Jun; 39(6):405-19.
  • Burger A., Drug design and development. A realistic appraisal, J Med Chem. 1978 Jan;21(1):1-4.
  • Butcher EC, Berg EL, Kunkel EJ., Systems biology in drug discovery, Nat Biotechnol. 2004 Oct; 22(10):1253-9.
  • Byng MC, Whittaker JC, Cuthbert AP, Mathew CG, Lewis CM., SNP subset selection for genetic association studies, Ann Hum Genet. 2003 Nov;67(Pt 6):543-56.
  • Caceres M, Lachuer J, Zapala MA, Redmond JC, Kudo L, Geschwind DH, Lockhart DJ, Preuss TM, Barlow C, Elevated gene expression levels distinguish human from non-human primate brains, Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):13030-5.
  • Cajiao I, Zhang A, Yoo EJ, Cooke NE, Liebhaber SA., Bystander gene activation by a locus control region, EMBO J. 2004 Sep 29; 23(19):3854-63.
  • Caldwell GW, Ritchie DM, Masucci JA, Hageman W, Yan Z., The new pre-preclinical paradigm: compound optimization in early and late phase drug discovery, Curr Top Med Chem. 2001 Nov;1(5):353-66.
  • Caldwell G.W., Compound Optimization in Early and Late Phase Drug Discovery: Acceptable Pharmacokinetic Properties Utilizing Combined Physicochemical, In Vitro and In Vivo Screens, Frontiers in Medicinal Chemistry - Online, Volume 1, Number 1, January 2004, pp. 607-618(12).
  • Cancela JM, Van Coppenolle F, Galione A, Tepikin AV, Petersen OH., Transformation of local Ca2+ spikes to global Ca2+ transients: the combinatorial roles of multiple Ca2+ releasing messengers, EMBO J. 2002 Mar 1;21(5):909-19.
  • Capecchi MR., Altering the genome by homologous recombination, Science. 1989 Jun 16;244(4910):1288-92.
  • Capua I, Alexander DJ, Avian influenza: recent developments, Avian Pathol. 2004 Aug; 33(4):393-404.
  • Carey G., Genetic association study in psychiatry: analytical evaluation and a Recommendation, Am J Med Genet. 1994 Dec 15;54(4):311-7.
  • Carrington WA, Lisin D., Cluster computing for digital microscopy, Microsc Res Tech. 2004 Jun 1; 64(2):204-13.
  • Chalfie M, Tu Y, Euskirchen G, Ward WW, Prasher DC., Green fluorescent protein as a marker for gene expression, Science. 1994 Feb 11; 263(5148):802-5.
  • Chambers G, Lawrie L, Cash P, Murray GI, Proteomics: a new approach to the study of disease, J Pathol. 2000 Nov; 192(3):280-8.
  • Chan SW, Zilberman D, Xie Z, Johansen LK, Carrington JC, Jacobsen SE., RNA silencing genes control de novo DNA methylation, Science. 2004 Feb 27; 303(5662):1336.
  • Chan WC, Nie S., Quantum dot bioconjugates for ultrasensitive nonisotopic detection, Science. 1998 Sep 25; 281(5385):2016-8.
  • Chan WC, Maxwell DJ, Gao X, Bailey RE, Han M, Nie S., Luminescent quantum dots for multiplexed biological detection and imaging, Curr Opin Biotechnol. 2002 Feb; 13(1):40-6.
  • Chapman JM, Cooper JD, Todd JA, Clayton DG., Detecting disease associations due to linkage disequilibrium using haplotype tags: a class of tests and the determinants of statistical power, Hum Hered. 2003;56(1-3):18-31.
  • Chen, X., Velliste, M., Weinstein, S., Jarvik, J.W., and Murphy, R.F., Location proteomics-Building subcellular location tree from high resolution 3D fluorescence microcope images of randomly-tagged proteins. Manipulation and Analysis of Biomolecules, Cells, and Tissues, Proceedings of SPIE 2003; 4962: 298–306.
  • Chien JY, Friedrich S, Heathman MA, de Alwis DP, Sinha V., Pharmacokinetics/Pharmacodynamics and the stages of drug development: role of modeling and simulation, AAPS J. 2005 Oct 7;7(3):E544-59.
  • Chiu SH, Huskey SW., Species differences in N-glucuronidation, Drug Metab Dispos. 1998 Sep;26(9):838-47.
  • Cho, M.J., Thompson, D.P., Cramer, C.T., Vidmar, T.J. and Scieszka, J.F (1989). The Madin Darby canine kidney (MDCK) epithelial cell monolayer as a model cellular transport barrier, Pharmaceutical Research 6: 71-77
  • Chong S, Whitelaw E, Epigenetic germline inheritance, Curr Opin Genet Dev. 2004 Dec; 14(6):692-6.
  • Choy G, O'Connor S, Diehn FE, Costouros N, Alexander HR, Choyke P, Libutti SK., Comparison of noninvasive fluorescent and bioluminescent small animal optical imaging, Biotechniques. 2003 Nov;35(5):1022-6, 1028-30.
  • Christopoulos A, Christopoulos G, Morfis M, Udawela M, Laburthe M, Couvineau A, Kuwasako K, Tilakaratne N, Sexton PM., Novel receptor partners and function of receptor activity-modifying proteins, J Biol Chem. 2003 Jan 31; 278(5):3293-7. Epub 2002 Nov 21.
  • Citron M., Strategies for disease modification in Alzheimer's disease, Nat Rev Neurosci. 2004 Sep; 5(9):677-85.
  • Clayton AJ, Lassa fever, Marburg and Ebola virus diseases and other exotic diseases: is there a risk to Canada?, Can Med Assoc J. 1979 Jan 20;120(2):146-55.
  • Claverie J.-M., Gene Number. What If There Are Only 30,000 Human Genes?, Science 2001; 291: 1255–7.
  • Coffey RJ, Richards JS, Remmert CS, LeRoy SS, Schoville RR, Baldwin PJ., An introduction to critical paths, Qual Manag Health Care. 1992 Fall;1(1):45-54.
  • Cole, N. B. et al., Diffusional mobility of Golgi proteins in membranes of living cells. Science 1996;  273, 797–801.
  • Collins FS, Riordan JR, Tsui LC, The cystic fibrosis gene: isolation and significance, Hosp Pract (Off Ed). 1990 Oct 15;25(10):47-57.
  • Collins F.S., Green E.S., Guttmacher A.E., Guyer M.S., A vision for the future of genomics research, Nature, 2003, 422:835-847
  • Collins F.S., Morgan M, Patrinos A., Viewpoint: The Human Genome Project: Lessons from Large-Scale Biology. Science, 2003b, 300:286-290.
  • Collins, F.S., International Human Genome Sequencing Consortium, Finishing the euchromatic sequence of the human genome, Nature 2004, 431, 931 – 945.
  • Conrad C, Erfle H, Warnat P, Daigle N, Lorch T, Ellenberg J, Pepperkok R, Eils R, Automatic identification of subcellular phenotypes on human cell Arrays, Genome Res. 2004 Jun;14(6):1130-6.
  • Contag CH, Spilman SD, Contag PR, Oshiro M, Eames B, Dennery P, Stevenson DK, Benaron DA., Visualizing gene expression in living mammals using a bioluminescent reporter, Photochem Photobiol. 1997 Oct;66(4):523-31.
  • Cornelissen, F., Wouters, L., Ver Donck, L., Verellen, G., Geerts, H., Automatic quantification of the effect of cardioprotective drugs in isolated myocytes, Bioimaging, 1993,  1, 197-206.
  • Cornelussen RN, Ver Donck L, Verellen G, Borgers M, van der Vusse GJ, Reneman RS, Snoeckx LH., Calcium homeostasis in cardiomyocytes isolated from heat-shocked rats, Am J Physiol. 1996 Nov;271(5 Pt 2):H1938-46.
  • Cozens DD., Abnormalities of the external form and of the skeleton in the New Zealand white rabbit, Food Cosmet Toxicol. 1965 Nov-Dec;3(5):695-700.
  • Craig JM., Heterochromatin--many flavours, common themes, Bioessays. 2005 Jan; 27(1):17-28.
  • Crawford L.M., D.V.M., Ph.D., Acting Commissioner of the FDA, Speech for Banc of America Securities Healthcare Institutional Investor Conference, 7 July 2004.
  • Crawford M, Woodman R, Ko Ferrigno P., Peptide aptamers: tools for biology and drug discovery, Brief Funct Genomic Proteomic. 2003 Apr;2(1):72-9.
  • Cremer T, Kupper K, Dietzel S, Fakan S., Higher order chromatin architecture in the cell nucleus: on the way from structure to function, Biol Cell. 2004 Oct;96(8):555-67.
  • Crentsil V., The pharmacogenomics of Alzheimer's disease, Ageing Res Rev. 2004 Apr;3(2):153-69.
  • Crick, F.H.C., Codon-Anticodon Pairing: The Wobble Hypothesis, J. Mol. Biol. 1966, 19:548-555.
  • Crosthwaite SK., Circadian clocks and natural antisense RNA, FEBS Lett. 2004 Jun 1; 567(1):49-54.
  • Crusio WE., Flanking gene and genetic background problems in genetically manipulated mice, Biol Psychiatry. 2004 Sep 15;56(6):381-5.
  • Cullen BR., Transcription and processing of human microRNA precursors, Mol Cell. 2004 Dec 22; 16(6):861-5.
  • Czermin B, Imhof A., The sounds of silence--histone deacetylation meets histone methylation, Genetica. 2003 Mar; 117(2-3):159-64.
  • Danuser G, Waterman-Storer CM., Quantitative fluorescent speckle microscopy: where it came from and where it is going, J Microsc. 2003 Sep;211(Pt 3):191-207.
  • Darvasi A., Experimental strategies for the genetic dissection of complex traits in animal models, Nat Genet. 1998 Jan; 18(1):19-24.
  • Darvasi A, Pisante-Shalom A., Complexities in the genetic dissection of quantitative trait loci, Trends Genet. 2002 Oct; 18(10):489-91.
  • Davidson MH., Controversy surrounding the safety of cerivastatin, Expert Opin Drug Saf. 2002 Sep;1(3):207-12.
  • Davie C, Pierre-Valentin J, Pollard C, Standen N, Mitcheson J, Alexander P, Thong B., Comparative pharmacology of guinea pig cardiac myocyte and cloned hERG (I(Kr)) channel, J Cardiovasc Electrophysiol. 2004 Nov;15(11):1302-9.
  • Davies J, New pathogens and old resistance genes, Microbiologia. 1994 Mar-Jun;10(1-2):9-12.
  • Davies E, Stankovic B, Azama K, Shibata K, Abe S., Novel components of the plant cytoskeleton: A beginning to plant "cytomics",  Plant Science, Invited Review, Plant Science 2001; (160)2: 185-196.
  • Day R, Beck DA, Armen RS, Daggett V., A consensus view of fold space: combining SCOP, CATH, and the Dali Domain Dictionary, Protein Sci. 2003 Oct;12(10):2150-60.
  • Dean M, et al., Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CCR5 structural gene. Science 1996, 273: 1856-1862.
  • Dean P., Mascio L., Ow D., Sudar D., Mullikin J., Proposed standard for image cytometry data files, Cytometry, 1990; 11:561-569.
  • De Brabander M, De Mey J, Joniau M, Geuens S, Immunocytochemical visualization of microtubules and tubulin at the light- and electron-microscopic level, J Cell Sci. 1977 Dec;28:283-301.
  • De Brabander M, Nuydens R, Geuens G, Moeremans M, De Mey J, The use of submicroscopic gold particles combined with video contrast enhancement as a simple molecular probe for the living cell, Cell Motil Cytoskeleton. 1986; 6(2):105-13.
  • De Brabander M, Geuens G, Nuydens R, Moeremans M, De Mey J., Microtubule-dependent intracellular motility investigated with nanometer particle video ultramicroscopy (nanovid ultramicroscopy), Ann N Y Acad Sci. 1986b;466:666-8.
  • De Brabander M, Geerts H, Nuydens R, Nuyens R., Detection of gold probes with video-enhanced contrast microscopy: nanovid microscopy, Am J Anat. 1989 Jun-Jul;185(2-3):282-95. 
  • Decaestecker K, Decaestecker E, Castellani C, Jaspers M, Cuppens H, De Boeck K, Genotype/phenotype correlation of the G85E mutation in a large cohort of cystic fibrosis patients, Eur Respir J. 2004 May;23(5):679-84.
  • De Duve C, Pressman B C, Gianetto R, Wattiaux R and Appelmans F., Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue, Biochemical Journal 1955, 60:604-17.
  • De Duve, Wattiaux R., Functions of lysosomes, Annu. Rev. Physiol. 1966; 28:435-492.
  • de Klein A, van Kessel AG, Grosveld G, Bartram CR, Hagemeijer A, Bootsma D, Spurr NK, Heisterkamp N, Groffen J, Stephenson JR., A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia, Nature. 1982 Dec 23;300(5894):765-7.
  • Delahunt CS, Lassen LJ., Thalidomide syndrome in monkeys, Science 1964 Dec 4;146:1300-5
  • De Mey J, Hoebeke J, De Brabander M, Geuens G, Joniau M, Immunoperoxidase visualisation of microtubules and microtubular proteins, Nature 1976 Nov 18; 264(5583):273-5.
  • De Mey, J., Moeremans, M., Geuens, G., Nuydens, R., De Brabander, M., High resolution light and electron microscopic localization of tubulin with the IGS (immuno-gold staining) method, Cell Biol. Int. Rep. 1981, 5, 889-899.
  • De Ridder F., Predicting the outcome of phase III trials using phase II data: a case study of clinical trial simulation in late stage drug development, Basic Clin Pharmacol Toxicol. 2005 Mar;96(3):235-41.
  • DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM, Use of a cDNA microarray to analyse gene expression patterns in human cancer, Nat Genet. 1996 Dec;14(4):457-60.
  • Deuschle K, Fehr M, Hilpert M, Lager I, Lalonde S, Looger LL, Okumoto S, Persson J, Schmidt A, Frommer WB, Genetically encoded sensors for metabolites, Cytometry A. 2005 Mar; 64A(1):3-9.
  • Dickson M, Gagnon JP., Key factors in the rising cost of new drug discovery and development, Nat Rev Drug Discov. 2004 May;3(5):417-29.
  • Dietmann S, Holm L., Identification of homology in protein structure classification, Nat Struct Biol. 2001 Nov;8(11):953-7.
  • DiMasi, J.A., Risks, Regulation, and Rewards in New Drug Development in the United States, Regulatory Toxicology and Pharmacology, 1994, Vol. 19.
  • DiMasi J.A., New drug development in the United States 1963-1999, Clin Pharmacol Ther, 69:286-296.
  • DiMasi J.A., Risks in new drug development: approval success rates for investigational drugs, Clin Pharmacol Ther, 69:297-307.
  • DiMasi J.A., Hansen RW, Grabowski HG., The price of innovation: new estimates of drug development costs, J Health Econ. 2003 Mar;22(2):325-30.
  • De Schutter E., Computational Neuroscience: Trends in research 2004, (Guest editorial), Neurocomputing 2004, 58-60, xix-xxi
  • Di L, Kerns EH., Application of pharmaceutical profiling assays for optimization of drug-like properties, Curr Opin Drug Discov Devel. 2005 Jul;8(4):495-504.
  • Dimitrova D. S., Berezney R., The spatio-temporal organization of DNA replication sites is identical in primary, immortalized and transformed mammalian cells, Journal of Cell Science 115, 4037-4051 (2002).
  • Dockray GJ., The biosynthesis of regulatory peptides, Am Rev Respir Dis. 1987 Dec; 136(6 Pt 2):S9-15.
  • Doria A., Methods for the study of the genetic determinants of diabetes and its complications, Przegl Lek. 2000; 57 Suppl 3:7-12.
  • Doss MX, Koehler CI, Gissel C, Hescheler J, Sachinidis A., Embryonic stem cells: a promising tool for cell replacement therapy, J Cell Mol Med. 2004 Oct-Dec;8(4):465-73.
  • Dulbecco R., A turning point in cancer research: Sequencing the genome, Science, 1986, 231: 1055-56.
  • Dracopoli NC., Pharmacogenomic applications in clinical drug development, Cancer Chemother Pharmacol. 2003 Jul;52 Suppl 1:S57-60. Epub 2003 Jun 18.
  • Drake B, Prater CB, Weisenhorn AL, Gould SA, Albrecht TR, Quate CF, Cannell DS, Hansma HG, Hansma PK., Imaging crystals, polymers, and processes in water with the atomic force microscope, Science. 1989 Mar 24;243(4898):1586-9.
  • Drews J, Drug Discovery: A Historical Perspective, Science 17 March 2000; 287: 1960-1964
  • Drews, J., In Quest of Tomorrows Medicines, Springer-Verlag, 1999.
  • Drucker-Colin R, Verdugo-Diaz L., Cell transplantation for Parkinson's disease: present status, Cell Mol Neurobiol. 2004 Jun;24(3):301-16.
  • Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, Zimmermann J, Lydon NB., Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells, Nat Med. 1996 May;2(5):561-6.
  • Druker BJ, Lydon NB., Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia, J Clin Invest. 2000 Jan;105(1):3-7..
  • Duesberg P., Rausch C., Rasnick D., Hehlmann R., Genetic instability of cancer cells is proportional to their degree of aneuploidy, Proc Natl Acad Sci U S A. 1998 November 10; 95 (23): 13692-13697.
  • Duesberg P, Fabarius A, Hehlmann R., Aneuploidy, the primary cause of the multilateral genomic instability of neoplastic and preneoplastic cells, IUBMB Life. 2004 Feb;56(2):65-81.
  • Dundr M, McNally JG, Cohen J, Misteli T., Quantitation of GFP-fusion proteins in single living cells, J Struct Biol. 2002 Oct-Dec;140(1-3):92-9.
  • Dupuy D, Li QR, Deplancke B, Boxem M, Hao T, Lamesch P, Sequerra R, Bosak S, Doucette-Stamm L, Hope IA, Hill DE, Walhout AJ, Vidal M, A first version of the Caenorhabditis elegans Promoterome, Genome Res. 2004 Oct; 14(10B):2169-75.
  • Dyer C., UK patients seek compensation after taking rofecoxib, BMJ. 2004 Dec 4;329(7478):1308.
  • Dzhambazov B, Teneva I, Koleva L, Asparuhova D, Popov N., Morphological, genetic and functional variability of a T-cell hybridoma line, Folia Biol (Praha). 2003;49(2):87-94.
  • Eakin, Hugh, Bayer Says Baycol Costs May Exceed Its Insurance, New York Times, March 14, 2003.
  • Ecker RC, de Martin R, Steiner GE, Schmid JA, Application of spectral imaging microscopy in cytomics and fluorescence resonance energy transfer (FRET) analysis, Cytometry,  2004 Jun;59A(2):172-81.
  • Ecker RC, Steiner GE., Microscopy-based multicolor tissue cytometry at the single-cell level, Cytometry. 2004b Jun;59A(2):182-90.
  • Edland SD, Slager S, Farrer M., Genetic association studies in Alzheimer's disease research: challenges and opportunities, Stat Med. 2004 Jan 30;23(2):169-78.
  • Edlund, H.: Transcribing Pancreas. Diabetes, 1998; 47:1817-1823
  • Edwards BS, Oprea T, Prossnitz ER, Sklar LA., Flow cytometry for high-throughput, high-content screening, Curr Opin Chem Biol. 2004 Aug;8(4):392-8.
  • Egner, A., Verrier S., Goroshkov A., Sφling H.-D., Hell S. W., 4Pi-microscopy of the Golgi apparatus in live mammalian cells, J. Struct. Biol. 2004; 147(1): 70-76.
  • Eikelenboom P, van Gool WA., Neuroinflammatory perspectives on the two faces of Alzheimer's disease, J Neural Transm. 2004 Mar;111(3):281-94. Epub 2003 Dec 03.
  • Eils R, Athale C., Computational imaging in cell biology, J Cell Biol. 2003 May 12;161(3):477-81.
  • Ekker SC., Morphants: a new systematic vertebrate functional genomics approach, Yeast. 2000 Dec;17(4):302-306..
  • Elkin S, Geddes D., Pseudomonal infection in cystic fibrosis: the battle continues, Expert Rev Anti Infect Ther. 2003 Dec;1(4):609-18.
  • Ellenberg, J., et al. Nuclear membrane dynamics and reassembly in living cells: targeting of an inner nuclear membrane protein in interphase and mitosis. J. Cell Biol. 1997; 138, 1193–1206.
  • Ellington AD, Szostak JW, In vitro selection of RNA molecules that bind specific ligands., Nature, 1990 Aug 30;346(6287):818-22.
  • Ellis C., Nature Reviews Drug Discovery GPCR Questionnaire Participants., The state of GPCR research in 2004., Nat Rev Drug Discov. 2004 Jul; 3(7):575, 577-626.
  • El-Osta A., Understanding the Consequences of Epigenetic Mechanisms and Its Effects on Transcription in Health and Disease, Cancer Biol Ther. 2004 Sep 23;3(9).
  • Emptage NJ., Fluorescent imaging in living systems, Curr Opin Pharmacol. 2001 Oct;1(5):521-5.
  • Entzeroth M, Emerging trends in high-throughput screening, Curr Opin Pharmacol. 2003 Oct;3(5):522-9.
  • Eckhardt F, Beck S, Gut IG, Berlin K, Future potential of the Human Epigenome Project, Expert Rev Mol Diagn. 2004 Sep;4(5):609-18.
  • Erickson RP., Mouse models of human genetic disease: which mouse is more like a man?, Bioessays. 1996 Dec; 18(12):993-8.
  • Eungdamrong NJ, Iyengar R., Modeling cell signaling networks, Biol Cell. 2004 Jun; 96(5):355-62.
  • Evans MJ, Kaufman MH., Establishment in culture of pluripotential cells from mouse embryos, Nature 1981; 292: 154–156.
  • Fajans SS, Bell GI, Polonsky KS, Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young, N Engl J Med. 2001 Sep 27;345(13):971-80.
  • Fan GY, Fujisaki H, Miyawaki A, Tsay RK, Tsien RY, Ellisman MH., Video-rate scanning two-photon excitation fluorescence microscopy and ratio imaging with cameleons, Biophys J. 1999 May;76(5):2412-20
  • Fauci AS, Host factors and the pathogenesis of HIV-induced disease, Nature 1996, 384: 529-533.
  • Fauci AS., Emerging infectious diseases: a clear and present danger to humanity, JAMA. 2004 Oct 20; 292(15):1887-8.
  • Fergusson D, Doucette S, Glass KC, Shapiro S, Healy D, Hebert P, Hutton B., Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials, BMJ. 2005 Feb 19;330(7488):396.
  • Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., Mello C.C., Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans, Nature 1998; 391:806 – 811.
  • Fischer JA, Muff R, Born W., Functional relevance of G-protein-coupled-receptor-associated proteins, exemplified by receptor-activity-modifying proteins (RAMPs), Biochem Soc Trans. 2002 Aug; 30(4):455-60.
  • Fitzgerald GA., Opinion: anticipating change in drug development: the emerging era of translational medicine and therapeutics, Nat Rev Drug Discov. 2005 Oct;4(10):815-8..
  • Fleming, A, On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae, The British Journal of Experimental Pathology, 1929; Vol. X, 226-236.
  • Foord SM., Matching accessories, Sci STKE. 2003 Jul 08; 2003(190):pe25.
  • Ford D, et al., Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium, Am J Hum Genet. 1998 Mar; 62(3):676-89.
  • Fortna A, Kim Y, MacLaren E, Marshall K, Hahn G, Meltesen L, Brenton M, Hink R, Burgers S, Hernandez-Boussard T, Karimpour-Fard A, Glueck D, McGavran L, Berry R, Pollack J, Sikela JM., Lineage-specific gene duplication and loss in human and great ape evolution, PLoS Biol. 2004 Jul; 2(7):E207. Epub 2004 Jul 13.
  • Fowler BA., Molecular biomarkers: Challenges and prospects for the future, Toxicol Appl Pharmacol. 2005 Aug 7;206(2):97.
  • Frank RE, Bartholomew DW, Cystic fibrosis--a genetic dilemma, J Insur Med. 2004; 36(2):158-61.
  • Fraser A., Towards full employment: using RNAi to find roles for the redundant, Oncogene. 2004 Nov 1; 23(51):8346-52.
  • Frodsham AJ, Hill AV., Genetics of infectious diseases, Hum Mol Genet. 2004 Oct 1; 13 Spec No 2:R187-94.
  • Fry JR., The metabolism of drugs by isolated hepatocytes, Q Rev Drug Metab Drug Interact. 1982;4(2-3):99-122.
  • Fuhr U., Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance, Drug Saf. 1998 Apr;18(4):251-72.
  • Furberg CD, Pitt B., Withdrawal of cerivastatin from the world market, Curr Control Trials Cardiovasc Med. 2001;2(5):205-207.
  • Garcia-Otin AL, Guillou F., Mammalian genome targeting using site-specific recombinases, Front Biosci. 2006 Jan 1;11:1108-36.
  • Garner C, Slatkin M., On selecting markers for association studies: patterns of linkage disequilibrium between two and three diallelic loci, Genet Epidemiol. 2003 Jan; 24(1):57-67.
  • Gattei V, Aldinucci D, Petti MC, Da Ponte A, Zagonel V, Pinto A., In vitro and in vivo effects of 5-aza-2'-deoxycytidine (Decitabine) on clonogenic cells from acute myeloid leukemia patients, Leukemia. 1993 May; 7 Suppl 1:42-8.
  • Gaush, C.R., Hard, W.L. and Smith, T.E., Characterization of an established line of canine kidney cells (MDCK), Proceedings of the Society for Experimental Biology and Medicine. 1966 122: 931-935
  • Gautier S, Bachelet H, Bordet R, Caron J., The cost of adverse drug reactions, Expert Opin Pharmacother. 2003 Mar;4(3):319-26.
  • Geerts H, De Brabander M, Nuydens R, Geuens S, Moeremans M, De Mey J, Hollenbeck P., Nanovid tracking: a new automatic method for the study of mobility in living cells based on colloidal gold and video microscopy, Biophys J. 1987 Nov; 52(5):775-82.
  • Geerts H, Nuydens R, Nuyens R, Ver Donck L., The effect of flunarizine on intracellular calcium in isolated rat cardiomyocytes, A digital image processing study, Cardiovasc Res. 1989 Sep;23(9):797-806, Erratum in: Cardiovasc Res 1989 Nov; 23(11):992.
  • Geerts H, de Brabander M, Nuydens R, Nanovid microscopy, Nature. 1991 Jun; 27;351(6329):765-6.
  • Geerts, H., Nuydens, R., Nuyens, R., Cornelissen, F., Quantification of fast axonal transport by video microscopy, Methods in Neurosciences, 1992; 10, p.297-314.
  • Geerts H, Nuydens R, De Jong M, Cornelissen F, Nuyens R, Wouters L., Sabeluzole stabilizes the neuronal cytoskeleton, Neurobiol Aging. 1996; Jul-Aug;17(4):573-81.
  • Gehan EA, Schneiderman MA., Historical and methodological developments in clinical trials at the National Cancer Institute, Stat Med. 1990 Aug;9(8):871-80; discussion 903-6.
  • George SR, O'Dowd BF, Lee SP., G-protein-coupled receptor oligomerization and its potential for drug discovery, Nat Rev Drug Discov. 2002 Oct; 1(10):808-20.
  • George TC, Basiji DA, Hall BE, Lynch DH, Ortyn WE, Perry DJ, Seo MJ, Zimmerman CA, Morrissey PJ, Distinguishing modes of cell death using the ImageStream multispectral imaging flow cytometer, Cytometry, 2004: Jun;59A(2):237-45.
  • Georgiou-Karistianis N, Smith E, Bradshaw JL, Chua P, Lloyd J, Churchyard A, Chiu E., Future directions in research with presymptomatic individuals carrying the gene for Huntington's disease, Brain Res Bull. 2003 Jan 30;59(5):331-8.
  • Gerard E, Infectious diseases in air travellers arriving in the UK, J R Soc Health. 2002 Jun;122(2):86-8.
  • Gerlich D, Mattes J, Eils R., Quantitative motion analysis and visualization of cellular structures, Methods. 2003 Jan;29(1):3-13.
  • Gerlich D, Ellenberg J., 4D imaging to assay complex dynamics in live specimens, Nat Cell Biol. 2003b Sep;Suppl:S14-9.
  • Gerster AO, Trumpfheller C, Racz P, Osmancik P, Tenner-Racz K, Tarnok A., Quantitative histology by multicolor slide-based cytometry, Cytometry. 2004 Oct;61A(2):210-9.
  • Geuens G, Gundersen GG, Nuydens R, Cornelissen F, Bulinski JC, DeBrabander M, Ultrastructural colocalization of tyrosinated and detyrosinated alpha-tubulin in interphase and mitotic cells, J Cell Biol. 1986 Nov;103(5):1883-93.
  • Geusebroek J.M., Cornelissen F., Smeulders A. W. M., Geerts H., Robust autofocusing in microscopy, Cytometry 2000, 39(1):1-9.
  • Geusebroek J.M., van den Boomgaard R., Smeulders A.W.M., Geerts H., Color invariance, IEEE Trans. Pattern Anal. Machine Intell., 2001; 23(12):1338-1350.
  • Geusebroek J. M., van den Boomgaard R., Smeulders A. W. M., Gevers T., Color constancy from physical principles. Pat. Rec. Let. 2003; 24(11):1653-1662.
  • Geusebroek J. M., Smeulders A. W. M., van de Weijer J., Fast anisotropic gauss filtering, IEEE Trans. Image Processing 2003b; 12(8):938-943.
  • Geusebroek J.M, Smeulders A. W. M., A six-stimulus theory for stochastic texture. Int. J. Comput. Vision April/May 2005; 62(1/2):7-16.
  • Gey G.O., CoffmanW.D., Kubicek M.T, Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium, Cancer Res., 12: 264-265, 1952.
  • Giavitto JL, Michel O., Modeling the topological organization of cellular processes, Biosystems. 2003 Jul;70(2):149-63..
  • Gillen PB, Ebola and the filoviruses: reducing the threat by improving Third World medical care and education of aircrew members, Air Med J. 1999 Oct-Dec;18(4):156-9.
  • Giuliano KA, Taylor DL., Fluorescent-protein biosensors: new tools for drug discovery, Trends Biotechnol. 1998 Mar; 16(3):135-40.
  • Giuliano KA, Haskins JR, Taylor DL, Advances in high content screening for drug discovery, Assay Drug Dev Technol. 2003 Aug;1(4):565-77.
  • Gobburu JV, Marroum PJ., Utilisation of pharmacokinetic-pharmacodynamic modelling and simulation in regulatory decision-making, Clin Pharmacokinet. 2001;40(12):883-92.
  • Gordon JW, Scangos GA, Plotkin DJ, Barbosa JA, Ruddle FH., Genetic transformation of mouse embryos by microinjection of purified DNA, Proc Natl Acad Sci U S A. 1980 Dec;77(12):7380-4.
  • Gong JP, From genomics, proteomics to cytomics, or from cytometry to cytomics, Ai Zheng, 2003 May;22(5):449-51 (article in Chinese)
  • Gottschalk R, Preiser W., Bioterrorism: is it a real threat?,Med Microbiol Immunol (Berl). 2004 Sep 2 (Epub)
  • Goud B., Small GTP-binding proteins as compartmental markers, Semin Cell Biol. 1992 Oct; 3(5):301-7.
  • Grabowski H, Vernon J, DiMasi JA, Returns on research and development for 1990s new drug introductions, Pharmacoeconomics. 2002;20 Suppl 3:11-29.
  • Graham TR., Membrane targeting: getting Arl to the Golgi, Curr Biol. 2004 Jun 22; 14(12):R483-5.
  • Grasela TH, Fiedler-Kelly J, Walawander CA, Owen JS, Cirincione BB, Reitz KE, Ludwig EA, Passarell JA, Dement CW., Challenges in the transition to model-based development, AAPS J. 2005 Oct 5;7(2):E488-95. .
  • Greene LA, Tischler AS., Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor, Proc Natl Acad Sci U S A. 1976 Jul;73(7):2424-8.
  • Griffin JP., Prepulsid withdrawn from UK and US markets, Adverse Drug React Toxicol Rev. 2000 Aug;19(3):177.
  • Grody WW.,  Molecular genetic risk screening, Annu. Rev. Med. 2003, 54,473-490.
  • Grunfeld GB., Modern medicine and the emergence of biomedical ethics, Caduceus. 1992 Spring;8(1):1-22.
  • Gunnell D, Saperia J, Ashby D., Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review, BMJ. 2005 Feb 19;330(7488):385.
  • Gust ID, Hampson AW, Lavanchy D, Planning for the next pandemic of influenza, Rev Med Virol. 2001 Jan-Feb;11(1):59-70.
  • Gustafsson MG., Extended resolution fluorescence microscopy, Curr Opin Struct Biol. 1999 Oct; 9(5):627-34.
  • Guttmacher A., Collins F., Genomic Medicine - A Primer. New England Journal of Medicine, 2002; 19:1512-1520.
  • Guttmacher, A., Collins F., Welcome to the genomic era. Editorial: New England Journal of Medicine, 2003, 349:996-998.
  • Guzey C, Spigset O., Genotyping as a tool to predict adverse drug reactions, Curr Top Med Chem. 2004;4(13):1411-21.
  • Haggarty SJ., The principle of complementarity: chemical versus biological space, Curr Opin Chem Biol. 2005 Jun;9(3):296-303.
  • Halapi E, Stefansson K, Hakonarson H., Population genomics of drug response, Am J Pharmacogenomics. 2004;4(2):73-82.
  • Hale M, Gillespie WR, Gupta SK, Tuk B, Holford NH., Clinical trial simulation: streamlining your drug development process, Applied Clinical Trials 1996 Aug;5(8):35-40.
  • Han M, Gao X, Su JZ, Nie S., Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules, Nat Biotechnol. 2001 Jul; 19(7):631-5.
  • Hansch C, Unger SH, Forsythe AB., Strategy in drug design. Cluster analysis as an aid in the selection of substituents, J Med Chem. 1973 Nov;16(11):1217-22.
  • Haraguchi T., Live cell imaging: approaches for studying protein dynamics in living cells, Cell Struct Funct. 2002 Oct; 27(5):333-4.
  • Haraguchi T, Shimi T, Koujin T, Hashiguchi N, Hiraoka Y., Spectral imaging fluorescence microscopy, Genes Cells. 2002b Sep;7(9):881-7.
  • Hardin PE., Transcription regulation within the circadian clock: the E-box and beyond, J Biol Rhythms. 2004 Oct; 19(5):348-60.
  • Hardy J, Selkoe DJ., The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science. 2002 Jul 19; 297(5580):353-6.
  • Harms E, Kivimae S, Young MW, Saez L., Posttranscriptional and posttranslational regulation of clock genes, J Biol Rhythms. 2004 Oct; 19(5):361-73.
  • Harrison A, Pearl F, Sillitoe I, Slidel T, Mott R, Thornton J, Orengo C., Recognizing the fold of a protein structure, Bioinformatics. 2003 Sep 22;19(14):1748-59.
  • Hartge P., Genes, hormones, and pathways to breast cancer, New Engl J Med. 2003 Jun 5; 348(23):2352-4.
  • Hartman JL 4th, Garvik B, Hartwell L., Principles for the buffering of genetic variation, Science. 2001 Feb 9; 291(5506):1001-4.
  • Hartman JL 4th, Tippery N.P., Systematic quantification of gene interactions by phenotypic array analysis, Genome Biol. 2004; 5(7): R49.
  • Hartwell, L.H., Hopfield, J.J., Leibler, S., and Murray, A.W., From molecular to modular cell biology, Nature 1999; 402: C47–52.
  • Hastings MH, Herzog ED., Clock genes, oscillators, and cellular networks in the suprachiasmatic nuclei, J Biol Rhythms. 2004 Oct; 19(5):400-13.
  • Hayashi M, Tice RR, MacGregor JT, Anderson D, Blakey DH, Kirsh-Volders M, Oleson FB Jr, Pacchierotti F, Romagna F, Shimada H, et al., In vivo rodent erythrocyte micronucleus assay, Mutat Res. 1994 Jun;312(3):293-304.
  • He Q, Li J, Bettiol E, Jaconi ME., Embryonic stem cells: new possible therapy for degenerative diseases that affect elderly people, J Gerontol A Biol Sci Med Sci. 2003 Mar; 58(3):279-87.
  • Heckl S, Pipkorn R, Nagele T, Vogel U, Kuker W, Voight K., Molecular imaging: Bridging the gap between neuroradiology and neurohistology, Histol Histopathol. 2004 Apr; 19(2):651-68.
  • Heit JJ, Kim SK., Embryonic stem cells and islet replacement in diabetes mellitus, Pediatr Diabetes. 2004 Dec; 5 Suppl 2:5-15.
  • Hell SW., Toward fluorescence nanoscopy, Nat Biotechnol. 2003 Nov; 21(11):1347-55.
  • Hell SW, Dyba M, Jakobs S., Concepts for nanoscale resolution in fluorescence microscopy, Curr Opin Neurobiol. 2004 Oct; 14(5):599-609.
  • Hengstler JG, Van der Burg B, Steinberg P, Oesch F., Interspecies differences in cancer susceptibility and toxicity, Drug Metab Rev. 1999 Nov;31(4):917-70.
  • Hermann A, Gerlach M, Schwarz J, Storch A., Neurorestoration in Parkinson's disease by cell replacement and endogenous regeneration, Expert Opin Biol Ther. 2004 Feb; 4(2):131-43.
  • Herz JM, Thomsen WJ, Yarbrough GG., Molecular approaches to receptors as targets for drug discovery, J Recept Signal Transduct Res. 1997 Sep;17(5):671-776.
  • Hesse J, Wechselberger C, Sonnleitner M, Schindler H, Schutz GJ., Single-molecule reader for proteomics and genomics, J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Dec 25; 782(1-2):127-35.
  • Heymann DL., The international response to the outbreak of SARS in 2003, Philos Trans R Soc Lond B Biol Sci. 2004 Jul 29; 359(1447):1127-9.
  • Hidalgo IJ, Raub TJ, Borchardt RT., Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 1989; 3:736-49.
  • Higgins G, Athey B, Bassingthwaighte J, Burgess J, Champion H, Cleary K, Dev P, Duncan J, Hopmeier M, Jenkins D, Johnson C, Kelly H, Leitch R, Lorensen W, Metaxas D, Spitzer V, Vaidehi N, Vosburgh K, Winslow R.
  • Final report of the meeting "modeling & simulation in medicine: towards an integrated framework". July 20-21, 2000, National Library of Medicine, National Institutes of Health, Bethesda, Maryland, USA, Comput Aided Surg. 2001;6(1):32-9.
  • Hinshelwood MM, Corbin CJ, Tsang PC, Simpson ER, Isolation and characterization of a complementary deoxyribonucleic acid insert encoding bovine aromatase cytochrome P450, Endocrinology. 1993 Nov; 133(5):1971-7.
  • Hoh, J.H., Hansma, P.K., Atomic force microscopy for high-resolution imaging in cell biology, Trends Cell Bio. 1992; 2:208-213.
  • Holford NH, Kimko HC, Monteleone JP, Peck CC., Simulation of clinical trials, Annu Rev Pharmacol Toxicol. 2000;40:209-34.
  • Holmes A, Lit Q, Murphy DL, Gold E, Crawley JN., Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background, Genes Brain Behav. 2003 Dec; 2(6):365-80.
  • Hondeghem LM, Lu HR, van Rossem K, De Clerck F., Detection of proarrhythmia in the female rabbit heart: blinded validation, J Cardiovasc Electrophysiol. 2003 Mar;14(3):287-94.
  • Hoogland C., Mostaguir K., Sanchez J.-C., Hochstrasser D.F., Appel R.D, SWISS-2DPAGE, ten years later, Proteomics 2004; 4(8):2352-2356.
  • Horn RJ., DICOM additions and advances: the standards committee works to keep up with technology, Healthc Inform. 2004 Sep;21(9):48, 50.
  • Horrobin DF, Innovation in the pharmaceutical industry, J R Soc Med, 2000; 93: 341-345
  • Horrobin DF, Realism in drug discovery-could Cassandra be right?, Nature biotechnology, 2001, 19, 1099-1100
  • Horrobin DF, Modern biomedical research: an internally self-consistent universe with little contact with medical reality?,Nat Rev Drug Discov. 2003 Feb;2(2):151-4.
  • Howe JG, Hershey JW, A sensitive immunoblotting method for measuring protein synthesis initiation factor levels in lysates of Escherichia coli, J Biol Chem. 1981 Dec 25;256(24):12836-9.
  • Hu, M., Li, Y., Davitt, C.M., Huang, S.M., Thummel, K., Penman, B.W. and Crespi, C.L., Transport and metabolic characterization of Caco-2 cells expressing CYP3A4 and CYP3A4 plus oxidoreductase. Pharmaceutical Research 1999 16: 1352-1359.
  • Huang, K., Velliste, M., and Murphy, R.F., Feature reduction for improved recognition of subcellular location pattern in fluorescence microscope images, Manipulation and Analysis of Biomolecules, Cells, and Tissues, Proceedings of SPIE 2003; 4962: 298–306.
  • Huang K., Murphy R. F., From Quantitative Microscopy to Automated Image Understanding, J. Biomed. Optics 2004; 9: 893-912
  • Huber LA., Is proteomics heading in the wrong direction?, Nat Rev Mol Cell Biol. 2003 Jan;4(1):74-80.
  • Hucker HB., Species differences in drug metabolism, Annu Rev Pharmacol. 1970;10:99-118.
  • Hull J, Thomson AH, Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis, Thorax. 1998 Dec;53(12):1018-21.
  • Hunter, J., Hirst, B.H. and Simmons, N.L., Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers. Pharmaceutical Research 1993 10: 743-749.
  • Huskey SE, Dean BJ, Bakhtiar R, Sanchez RI, Tattersall FD, Rycroft W, Hargreaves R, Watt AP, Chicchi GG, Keohane C, Hora DF, Chiu SH., Brain penetration of aprepitant, a substance P receptor antagonist, in ferrets, Drug Metab Dispos. 2003 Jun;31(6):785-91.
  • Iannuzzi MC, Collins FS, Reverse genetics and cystic fibrosis, Am J Respir Cell Mol Biol. 1990 Apr;2(4):309-16.
  • Iborra F, Cook PR, Jackson DA., Applying microscopy to the analysis of nuclear structure and function, Methods. 2003 Feb;29(2):131-41.
  • Ideker T., Galitski T.,Hood L.,A new Approach to decoding life: Systems Biology, Annu. Rev. Genomics Hum. Genet., 2001, 2:343–72.
  • Ikeda M., Calcium dynamics and circadian rhythms in suprachiasmatic nucleus neurons, Neuroscientist. 2004 Aug; 10(4):315-24.
  • Iketaki Y, Watanabe T, Ishiuchi S, Sakai M, Omatsu T, Yamamoto K, Fujii M., Predicted spatial resolution of su